Study on immune system tools for TB diagnosis
Part of Infections, Lungs & breathing clinical trials.
This study aims to better understand how the immune system responds to tuberculosis (TB) and improve tools for diagnosing and managing the disease. It may help people with active TB, their close contacts, people with certain other lung diseases, or healthy individuals.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 65 years old
- You have no known or suspected immune system problems (like HIV or taking drugs that weaken immunity)
- You are not pregnant or planning to become pregnant
- You belong to one of several groups: active TB, close contact with TB, other lung disease, or healthy without TB
- You are willing to provide a blood sample and have some tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
This study looks at how the immune system and natural germs in the lungs work in people who have recently been in close contact with someone with active tuberculosis (TB). It aims to better understand how the body responds to TB exposure.
This study tests new, faster ways to diagnose tuberculosis (TB) using samples like sputum (mucus from your lungs), tongue swabs, and urine. It aims to see if these new tests can find TB more accurately than current methods, which could help you get the right treatment sooner.
This study looks for TB bacteria in the blood of people with active tuberculosis and their close contacts at home. It aims to find better ways to detect TB early and prevent its spread.
This study tests rapid TB screening and lab-style diagnostic methods to see how well they find TB disease and TB that is resistant to rifampin (a key TB drug). It may help doctors diagnose TB faster and more accurately, especially in people at higher risk.
This study tests new tools that can check for tuberculosis (TB) more quickly at or near where care happens. It includes people with cough or TB risk factors, and also the health workers who perform TB testing, to see how well the tests work and how easy they are to use.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.